Drug Shortage Report for RAN-LISINOPRIL
Report ID | 83075 |
Drug Identification Number | 02294257 |
Brand name | RAN-LISINOPRIL |
Common or Proper name | RAN-LISINOPRIL |
Company Name | RANBAXY PHARMACEUTICALS CANADA INC. |
Market Status | DORMANT |
Active Ingredient(s) | LISINOPRIL |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 500 |
ATC code | C09AA |
ATC description | ACE INHIBITORS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-04-30 |
Estimated end date | 2019-06-28 |
Actual end date | 2019-06-21 |
Shortage status | Resolved |
Updated date | 2019-06-24 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2019-06-24 | French | Compare |
v5 | 2019-06-24 | English | Compare |
v4 | 2019-05-28 | French | Compare |
v3 | 2019-05-28 | English | Compare |
v2 | 2019-05-03 | French | Compare |
v1 | 2019-05-03 | English | Compare |
Showing 1 to 6 of 6